7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Equifax Inc.

by Todd Bunton

February 22, 2012 | Comments : 0 Recommended this article: (0)
EFX

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Estimates have been surging for Equifax Inc. ( EFX - Analyst Report ) after the company delivered strong fourth quarter results on February 8.

It is a Zacks #2 Rank (Buy) stock.

Based on current consensus estimates, analysts project 12% EPS growth this year and 11% growth next year. This is in-line with management's target EPS growth rate between 10-13% over the next three years.

On top of this, the company pays a dividend that yields a solid 1.5%.

Company Description

Equifax is one of the three major consumer credit reporting agencies in the United States. It was founded in 1899 and is headquartered in Atlanta, Georgia. It has a market cap of $5 billion.

Fourth Quarter Results

Equifax reported better than expected results for the fourth quarter on February 8. Earnings per share came in at 68 cents, beating the Zacks Consensus Estimate by a penny. It was a 10% increase over the same quarter in 2010.

Revenue rose 10% to $509.7 million, ahead of the Zacks Consensus Estimate of $502.0 million. This was driven in large part by a 13% increase in Total U.S. Consumer Information Solutions.

Meanwhile, the operating margin expanded from 22.8% of revenue to 24.7% in the quarter.

Outlook

Following strong Q4 results, analysts raised their estimates significantly higher for both 2012 and 2013, sending the stock to a Zacks #2 Rank (Buy).

The Zacks Consensus Estimate for 2012 is now $2.82, representing 12% growth over 2011 EPS. The 2013 consensus estimate is currently $3.13, corresponding with 11% growth.

This is in-line with the company's 3-year target of 10-13% EPS growth on revenue growth of 7-10% with steady margin expansion and financial leverage.

Dividend

Equifax also offers a dividend that yields a solid 1.5%.

After holding its quarterly dividend steady at 4 cents per share for several years, Equifax boosted it to 16 cents in late 2010.

Valuation

Although shares are up 7% since the company reported its fourth quarter results, the valuation picture still looks reasonable. Shares trade at 14.9x 12-month forward earnings, in-line with its historical median.

And its price to book ratio of 3.0 is well below its 10-year median of 5.1.

The Bottom Line

With strong EPS growth forecasts, rising estimates, a solid dividend and reasonable valuation, Equifax offers attractive total return potential.

Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Co-Editor of the Reitmeister Value Investor.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.